FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including a linear non-coding molecule of deoxyribonucleic acid with a non-closed chain having immune-stimulating properties, a pharmaceutical composition for the treatment of an infectious disease containing the above-mentioned linear non-coding DNA molecule, a method for the treatment of an infectious disease, and the use of a linear non-coding molecule of deoxyribonucleic acid with a non-closed chain or a pharmaceutical composition, when manufacturing a drug for the treatment of an infectious disease.
EFFECT: invention expands the arsenal of means for the treatment of infectious diseases.
19 cl, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MESOTHELINE-TARGETED CANCER VACCINES AND THEIR APPLICATION | 2018 |
|
RU2751252C1 |
| ANTI-LIGAND 1 ANTIBODY OF PROGRAMMED CELL DEATH (PD-L1), ITS ANTIGEN-BINDING FRAGMENT AND THEIR MEDICAL APPLICATION | 2016 |
|
RU2727914C2 |
| COMPOSITIONS CONTAINING ANTI-SEAMS 1 AND ANTI-PD ANTIBODIES FOR CANCER THERAPY | 2014 |
|
RU2697522C1 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPEUTIC REGIMENS BASED ON VACCINES | 2013 |
|
RU2737765C2 |
| DNA CONSTRUCT FOR EXPRESSION | 2011 |
|
RU2604186C2 |
| MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF | 2013 |
|
RU2663725C2 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPY SCHEMES BASED ON VACCINES | 2013 |
|
RU2609651C2 |
| ANTI-αvβ8 ANTIBODIES AND COMPOSITIONS AND THEIR USE | 2019 |
|
RU2812478C2 |
| MEDICINAL PRODUCT | 2017 |
|
RU2759728C2 |
| ANTICANCER VACCINES TARGETING BORIS AND METHODS OF THEIR APPLICATION | 2018 |
|
RU2759681C1 |
